Combino Pharm: Zoledronic Acid Ready to Use, A New Business Opportunity
Combino Pharm presents a new business opportunity with the product Zoledronic Acid (Ready to Use...
Combino Pharm presents a new business opportunity with the product Tobramycin for inhalation.
Product description: Tobramycin Solution for inhalation.
Reference product: Tobi® (Novartis).
Therapeutical indication: Management of cystic fibrosis patients with P. aeruginosa.
Presentation: Ampoule blow-fill-seal 300mg/5ml.
Highlights:
Patent status – EU: Ready to be launched/commercialised/marketed.
Regulatory Details:
Regulatory strategy: Dossier completed with granted MAs in PT and ES through DCP.
Combino Pharm presents a new business opportunity with the product Zoledronic Acid (Ready to Use...
Combino Pharm presents a new business opportunity with the product Memantine.1. Product Description: memantine hydrochloride2....
As always, Combino Pharm will be present at the CPhI, which this year is being...
Combino Pharm's R&D facilities are based in Sant Joan Despí, Barcelona, with an R&D Center...